XML 15 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Convertible Preferred Stock and Changes In Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Convertible Preferred Stock
Preferred Stock
Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated other comprehensive (loss) gain
Balance, before retroactive conversion $ (55,692)   $ 87,140 $ 2 $ 6,521 $ (62,215)  
Retroactive application       $ (1) 1    
Retroactive application, shares [1]     (152,677,720) (17,972,432)      
Balance, before retroactive conversion, shares [1]     199,145,285 23,442,353      
Beginning balance at Dec. 31, 2022 (55,692)   $ 87,140 $ 1 6,522 (62,215)  
Beginning balance, shares at Dec. 31, 2022 [1]     46,467,565 5,469,921      
Issuance of common stock upon exercise of stock options 215       215    
Issuance of common stock upon exercise of stock options, shares [1]       433,906      
Stock-based compensation expense 3,808       3,808    
Issuance of common stock in connection with the acquisition of fSight 10,077       10,077    
Issuance of common stock in connection with the acquisition of fSight, shares [1]       1,306,385      
Purchase price adjustment in connection with the fSight acquisition 898       898    
Forfeitures of restricted stock and restricted stock surrendered in lieu of withholding taxes (91)       (91)    
Forfeitures of restricted stock and restricted stock surrendered in lieu of withholding taxes, shares [1]       (11,832)      
Convertible preferred stock dividends         12,581 (12,581)  
Convertible preferred stock dividends, shares [1]     1,258,055        
Issuance of preferred stock upon exercise of preferred warrants 2,008       2,008    
Issuance of preferred stock upon exercise of preferred warrants, shares [1]     193,372        
Conversion of convertible preferred stock into common stock in connection with the Business Combination 87,140 $ (87,140)   $ 5 87,135    
Conversion of convertible preferred stock into common stock in connection with the Business Combination, shares [1]   (47,918,992)   47,918,992      
Issuance of common stock upon exercise of common warrants, shares [1]       1,491,229      
Stock Issued During Period, Shares, Acquisitions [1]       1,306,385      
Issuance of common stock upon Business Combination, shares [1]       1,818,519      
Issuance of common stock upon Business Combination, value 573       573    
Issuance of common stock upon exercise of common stock warrants, net of issuance costs and payments to warrant holders of non-redeemed warrants 3,653       3,653    
Issuance of common stock upon exercise of common stock warrants, net of issuance costs and payments to warrant holders of non-redeemed warrants, shares [1]       324,546      
Reclassification of convertible note derivative liability to equity 11,278       11,278    
Unrealized gain (loss) resulting from change in fair value of marketable securities (59)           $ (59)
Net loss (984)         (984)  
Ending balance at Dec. 31, 2023 62,824     $ 6 138,657 (75,780) (59)
Ending balance, shares at Dec. 31, 2023 [1]       58,751,666      
Issuance of common stock upon exercise of stock options $ 272       272    
Issuance of common stock upon exercise of stock options, shares 789,097     789,097      
Stock-based compensation expense $ 7,721       7,721    
Issuance of common stock in connection with the acquisition of fSight 375       375    
Issuance of common stock in connection with the acquisition of fSight, shares       252,288      
Issuance of common stock in connection with employee incentive restricted stock awards, shares       1,088,384      
Issuance of common stock in connection with at-the-market offering, net of offering costs       16,336      
Shares withheld for taxes upon restricted stock awards vesting (122)       (122)    
Shares withheld for taxes upon restricted stock awards vesting, shares       (97,641)      
Stock Issued During Period, Shares, Acquisitions       252,288      
Unrealized gain (loss) resulting from change in fair value of marketable securities 61           61
Net loss (62,746)         (62,746)  
Ending balance at Dec. 31, 2024 $ 8,385     $ 6 $ 146,903 $ (138,526) $ 2
Ending balance, shares at Dec. 31, 2024       60,800,130      
[1] The shares of the Company’s common and redeemable convertible preferred stock prior to the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 0.233335 established in the Business Combination as described in Note 3.